RxDoctor Payments Data

Christina Cooper, MD

Family Medicine · El Dorado, ARNPI 1194166199

Payments from drug & device makers

$3,093in general payments, 2019–2025

Across 226 payments — averaging $13.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Astellas Pharma US Inc$386
  • Novo Nordisk$239
  • AbbVie$176
  • Amgen$81
  • Pfizer$73
  • plus $340 from 12 others

What the payments were for

  • Food & beverage$3,093100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,093 in reported general payments places this provider in the 75th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$318,073
Medicare patients
649
Services billed
12,964

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab21$153,593
OzempicSemaglutide77$89,187
EliquisApixaban151$61,045
JardianceEmpagliflozin110$60,710
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$47,036
JanuviaSitagliptin Phosphate49$37,752
TrulicityDulaglutide39$35,413
MounjaroTirzepatide32$35,074
OxycontinOxycodone Hcl12$34,164
XareltoRivaroxaban57$25,728
LinzessLinaclotide34$25,336
FarxigaDapagliflozin Propanediol51$23,849
JanumetSitagliptin Phos/Metformin Hcl25$21,351
ShingrixVaricella-Zoster Ge/As01b/Pf83$18,263
Soliqua 100-33Insulin Glargine/Lixisenatide19$16,788

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$239$89,18777 claims
GSKTrelegy Ellipta, Shingrix, Breo Ellipta, Arexvy$49$87,608195 claims
Lilly USA, LLCTrulicity, Mounjaro$12$70,48771 claims
PfizerEliquis$73$61,045151 claims
AbbVieLinzess, Lumigan, Synthroid$176$34,639101 claims
Johnson & JohnsonXarelto$11$25,72857 claims
NovartisEntresto$31$12,99342 claims
Astellas Pharma US IncMyrbetriq$386$7,82225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in El Dorado

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →